Domperidone tablet is a peripheral dopamine receptor blocker, which directly acts on gastrointestinal wall. It can increase the tension of lower esophageal sphincter, prevent gastroesophageal reflux, enhance gastric peristalsis, promote gastric emptying, coordinate gastric and duodenal motility, inhibit nausea and vomiting, and effectively prevent bile reflux without affecting gastric juice secretion. Domperidone tablets can not easily pass the blood-cerebrospinal fluid barrier and inhibit dopamine receptors in the brain. Therefore, there are no neurological and psychiatric adverse reactions such as extrapyramidal system.

Market Analysis and Insights: Global Domperidone Market
In 2020, the global Domperidone market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Domperidone Scope and Market Size
The global Domperidone market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Domperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Tablets
Pellets
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Company
Schwitz Biotech
Luckys Pharma
Shreeji Pharma International
Xian Janssen Pharmaceutical
Hunan Qianjin Xiangjiang
Foshan Shouxin Pharmaceutical
Jiangxi Jiezhong Biochemistry
Meenaxy Pharma Pvt. Ltd
Hainan Asia Pharmaceutical
Lizhu Pharmaceutical Group
Jiangxi Huiren Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE